437 related articles for article (PubMed ID: 28208698)
1. Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.
Tosi U; Marnell CS; Chang R; Cho WC; Ting R; Maachani UB; Souweidane MM
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208698
[TBL] [Abstract][Full Text] [Related]
2. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
3. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
4. Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations.
Serwer LP; James CD
Adv Drug Deliv Rev; 2012 May; 64(7):590-7. PubMed ID: 22306489
[TBL] [Abstract][Full Text] [Related]
5. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Ferguson S; Lesniak MS
Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.
Virtanen PS; Ortiz KJ; Patel A; Blocher WA; Richardson AM
Curr Oncol Rep; 2024 Mar; 26(3):236-249. PubMed ID: 38329660
[TBL] [Abstract][Full Text] [Related]
7. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
8. Convection-enhanced delivery: from mechanisms to clinical drug delivery for diseases of the central nervous system.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2012; 52(8):531-8. PubMed ID: 22976134
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies to improve drug delivery across the blood-brain barrier.
Azad TD; Pan J; Connolly ID; Remington A; Wilson CM; Grant GA
Neurosurg Focus; 2015 Mar; 38(3):E9. PubMed ID: 25727231
[TBL] [Abstract][Full Text] [Related]
10. The use of convection-enhanced delivery with liposomal toxins in neurooncology.
Fiandaca MS; Berger MS; Bankiewicz KS
Toxins (Basel); 2011 Apr; 3(4):369-97. PubMed ID: 22069714
[TBL] [Abstract][Full Text] [Related]
11. Convection-Enhanced Delivery.
Mehta AM; Sonabend AM; Bruce JN
Neurotherapeutics; 2017 Apr; 14(2):358-371. PubMed ID: 28299724
[TBL] [Abstract][Full Text] [Related]
12. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
Mangraviti A; Gullotti D; Tyler B; Brem H
J Control Release; 2016 Oct; 240():443-453. PubMed ID: 27016141
[TBL] [Abstract][Full Text] [Related]
13. Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.
Papademetriou IT; Porter T
Ther Deliv; 2015; 6(8):989-1016. PubMed ID: 26488496
[TBL] [Abstract][Full Text] [Related]
14. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
Debinski W; Tatter SB
Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic considerations in the treatment of CNS tumours.
Motl S; Zhuang Y; Waters CM; Stewart CF
Clin Pharmacokinet; 2006; 45(9):871-903. PubMed ID: 16928151
[TBL] [Abstract][Full Text] [Related]
17. Intraparenchymal ultrasound application and improved distribution of infusate with convection-enhanced delivery in rodent and nonhuman primate brain.
Mano Y; Saito R; Haga Y; Matsunaga T; Zhang R; Chonan M; Haryu S; Shoji T; Sato A; Sonoda Y; Tsuruoka N; Nishiyachi K; Sumiyoshi A; Nonaka H; Kawashima R; Tominaga T
J Neurosurg; 2016 May; 124(5):1490-500. PubMed ID: 26495939
[TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced delivery to the central nervous system.
Lonser RR; Sarntinoranont M; Morrison PF; Oldfield EH
J Neurosurg; 2015 Mar; 122(3):697-706. PubMed ID: 25397365
[TBL] [Abstract][Full Text] [Related]
19. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
20. Drug and gene delivery across the blood-brain barrier with focused ultrasound.
Timbie KF; Mead BP; Price RJ
J Control Release; 2015 Dec; 219():61-75. PubMed ID: 26362698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
